BlackRock, Inc.

Position in OCUL — Ocular Therapeutix, Inc

CIK 2012383 New York, NY

Position in OCUL

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$190,277,763

+$53,631,846 QoQ

Shares Held

19,376,555

+20.1% QoQ

Ownership

8.82%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 257 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 96% Shared 0% None 4%

Healthcare · as of Jun 30, 2026

BlackRock, Inc. holds $84,995,048,474 across 474 Biotechnology names. OCUL ranks #86 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	24,109,373	$11,975,848,839
2	REGN	Regeneron Pharmaceuticals, Inc.	9,113,506	$5,682,635,520
3	ALNY	Alnylam Pharmaceuticals, Inc.	10,907,675	$3,283,537,392
4	RVMD	Revolution Medicines, Inc.	13,695,790	$2,564,947,540
5	MRNA	Moderna, Inc.	30,599,409	$2,142,876,602
6	INCY	Incyte Corp	18,032,718	$2,044,188,902
7	CYTK	Cytokinetics Inc	20,094,362	$1,711,838,691
8	ROIV	Roivant Sciences Ltd.	48,236,091	$1,707,075,250

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$149,536,681	15,227,768	—	Shares	Sole	2026-07-29
2026-06-30	$190,277,763	19,376,555	+20.1%	Shares	Sole	2026-08-07
2026-03-31	$136,645,917	16,132,931	+3.4%	Shares	Sole	2026-05-13
2025-12-31	$189,413,057	15,602,394	+47.8%	Shares	Sole	2026-02-12
2025-09-30	$123,409,417	10,556,837	+0.1%	Shares	Sole	2025-11-12
2025-06-30	$97,870,390	10,546,379	-12.2%	Shares	Sole	2025-08-12
2025-03-31	$88,050,864	12,012,397	+1.4%	Shares	Sole	2025-05-02
2024-12-31	$101,168,993	11,846,487	+4.3%	Shares	Sole	2025-02-07
2024-09-30	$98,781,222	11,354,164	—	Shares	Sole	2024-11-13
No filing history on record for this holder in this stock.